Search results
Results from the WOW.Com Content Network
Fluvoxamine, sold under the brand name Luvox among others, is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class. [8] It is primarily used to treat major depressive disorder and, perhaps more-especially, obsessive–compulsive disorder (OCD), [9] but is also used to treat anxiety disorders [10] such as panic disorder, social anxiety disorder, and post-traumatic stress ...
A new survey shows 10% of travelers have had medicine confiscated and more than 50% said that increased their anxiety during a trip.
[52] [53] [54] As of July 2021, a large number of drugs had been considered for treating COVID-19 patients. [55] As of November 2022, there was moderate-certainty evidence suggesting that dexamethasone, and systemic corticosteroids in general, probably cause a slight reduction in all-cause mortality (up to 30 days) in hospitalized patients with ...
A clinical study suggests a cheap antidepressant helps lower the risk of COVID hospitalization.. Fluvoxamine reduced hospitalization and long term observation rates by one-third in the study ...
This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.
A Charlotte woman pleaded guilty just this week to peddling a fake COVID-19 cure, federal prosecutors said. Fake COVID treatments are circulating. How to spot them and get real medication
Civica Rx is a nonprofit generic drug company founded in 2018 by leading U.S. health systems and philanthropies [1] for the purpose of preventing and mitigating drug shortages in the United States, and the price hikes that can accompany them. [2] Civica's mission is to make quality generic medicines accessible and affordable to everyone.
The drug was studied because of its anti-inflammatory effects, but the mechanism of action against COVID-19 remains uncertain. [38] [39] [40] On 16 December, the NIH found that use of fluvoxamine did not impact incidence of covid-related hospitalizations and considered the evidence insufficient to recommend either for or against the drug. [41]